1. P511: RISK FACTORS AND INCIDENCE OF CARDIAC EVENTS IN A LARGE COHORT OF 525 ADULT PATIENTS WITH NEWLY DIAGNOSED NON-M3 ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: Boluda, B.; Solana-Altabella, A.; Cano, I.; Martínez-Cuadrón, D.; Acuña-Cruz, E.; Torres-Miñana, L.; Rodríguez-Veiga, R.; Martínez-Campuzano, D.; García-Ruiz, R.; Lloret, P.; Asensi, P.; Serrano, A.; Osa-Sáez, A.; Agüero-Ramón-Llín, J.; Rodríguez-Serrano, M.; Buendía-Fuentes, F.; Megías-Vericat, ... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P512: PRELIMINARY RESULTS OF VEN-A-QUI STUDY: A PHASE 1-2 TRIAL TO ASSESS THE SAFETY AND EFFICACY OF THE COMBINATION OF AZACITIDINE OR LOW-DOSE CYTARABINE WITH VENETOCLAX AND QUIZARTINIB IN NEWLY DIAGNOSED. (23rd June 2022) Authors: Bergua-Burgues, J. M.; Rodríguez-Veiga, R.; Cano, I.; Vall-llovera, F.; García-Guiñon, A.; Gómez-Estruch, J.; Colorado, M.; Casas-Avilés, I.; Esteve-Reyner, J.; Verdugo, M. V.; Ramos, F.; Valero, M.; Acuña-Cruz, E.; Boluda, B.; Torres-Miñana, L.; Martínez-López, J.; Barragán, E.; Ayala, R.; Martí... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P520: PHASE 1/2 STUDY OF SEL24/MEN1703, A FIRST-IN-CLASS DUAL PIM/FLT3 KINASE INHIBITOR, IN PATIENTS WITH IDH1/2-MUTATED ACUTE MYELOID LEUKEMIA: THE DIAMOND-01 TRIAL. (23rd June 2022) Authors: Martinelli, G.; Santoro, A.; Gambacorti-Passerini, C.; Vives Polo, S.; Solomon, S. R.; Mukherjee, S.; Lech-Maranda, E.; Yair Levy, M.; Wierzbowska, A.; Calbacho-Robles, M.; Marconi, G.; Benedetta Giannini, M.; Cano, I.; Torres Miñana, L.; Acuña-Cruz, E.; Angelosanto, N.; Galleu, A.; Baldini, S.; ... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P586: IADADEMSTAT COMBINATION WITH AZACITIDINE SHOWS ENCOURAGING SAFETY AND EFFICACY DATA IN ELDERLY AND UNFIT AML PATIENTS. (23rd June 2022) Authors: Salamero, O.; Somervaille, T.; Molero, A.; Acuña-Cruz, E.; Perez-Simon, J. A.; Coll, R.; Arnan Sangerman, M.; Merchan, B.; Perez, A.; Cano, I.; Rodriguez-Veiga, R.; Arevalo, M.; Gutierrez, S.; Buesa, C.; Bosch, F.; Montesinos, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗